Project | Before treatment/baseline | Period of treatment/intervention and follow-up (14 days) | After the treatment/call-back | |
0 week (−5 to −1 days) | 1 week/day 7 | 2 weeks/day 14 | Within 4–8 weeks | |
Screening | × | |||
Informed consent | × | |||
Inclusion and exclusion criteria | × | |||
Medical history collection | × | |||
Vital signs | × | × | × | × |
Randomisation | × | |||
Blood routine test | × | × | ||
Urine routine test | × | × | ||
Renal function test | × | × | ||
liver function test | × | × | ||
ECG | × | × | ||
14C UBT | × | × | ||
Stool H. pylori antigen | × | × | ||
Specimens | × | × | ||
Treatment and follow-up | × | × | × | |
Concomitant medications | × | × | × | × |
AEs | × | × | × | |
Surplus medicines recycling | × |
The ‘×’ is the item or operation content that must be performed in the project.
14C UBT, 14C-urea breath test; AEs, adverse events.